Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: Analysis by Northern blotting andin situ hybridization
Open Access
- 29 October 1998
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 78 (3) , 286-292
- https://doi.org/10.1002/(sici)1097-0215(19981029)78:3<286::aid-ijc4>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.American Journal of Respiratory Cell and Molecular Biology, 1996
- Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.Journal of Clinical Investigation, 1995
- Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice.Proceedings of the National Academy of Sciences, 1995
- The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasionFibrinolysis, 1994
- The urokinase receptor: Structure, regulation and inhibitor-mediated internalizationFibrinolysis, 1994
- The urokinase receptorFibrinolysis, 1994
- Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor disseminationCancer, 1994
- Differential protease expression by cutaneous squamous and basal cell carcinomas.Journal of Clinical Investigation, 1991
- Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissuesCancer, 1991
- The pathogenesis of cancer metastasisNature, 1980